← Evidence map

ArticleCureus2022

A Single-Center Experience of Dopamine Antagonist ONC201 for Recurrent Histone H3 Lysine 27-to-Methionine (H3K27M)-Mutant Glioblastoma in Adults.

Chukwuyem Ekhator et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2022
2023
2024
2025
2026
2027
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 36148206